Singapore-headquartered Mirxes to join Alibaba, Tencent on Hang Seng Composite Index
I'm PortAI, I can summarize articles.
Singapore-based biotech firm Mirxes will join the Hang Seng Composite Index on September 8, enhancing its market profile and strategic position in Asian capital markets. The index includes major companies like Alibaba and Tencent, and Mirxes anticipates increased visibility and trading liquidity, attracting a broader investor base. Founded in 2014, Mirxes specializes in microRNA-based cancer detection, with its flagship product, GastroClear, being the first approved molecular blood test for early gastric cancer detection.
Source: Businesstimes The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments